Abstract Topics

Abstracts should address aspects of vascular surgery. Each abstract submission will be associated with a corresponding category found in the predefined list of categories (a total of 23 categories). The submitter is required to select the most appropriate category for the abstract in the online submission form. All entries should fall under one of the 23 categories below:

AAA – Abdominal Aortic & Iliac Aneurysm


ALI – Acute Limb Ischaemia

PAD – Peripheral Arterial Diseases (lower extremity)


Radiation Protection

Antithrombotic Therapy

Upper extremity arterial disease

Aortic Arch

Vascular & Lymphatic Malformations

Aortic Dissection

Vascular Access

Carotid & vertebral arteries disease

Vascular Imaging / diagnostic

CLTI – Chronic Limb-Threatening Ischaemia

Vascular Trauma

CVD – Chronic Venous Disease

Venous Thrombosis

Diabetic Foot

VGEI – Vascular Graft or Endograft Infection

DTA – Descending Thoracic Aorta Diseases

Wound care

Mesenteric and Renal Arteries and Veins


Submission is now closed

Key Dates: 

  • Abstract Submission closes: 12 April, 2023 (23:59 CEST)

  • Notification of Acceptance/Rejection: 22 May, 2023

  • Deadline to confirm presentation: 16 June, 2023

  • Deadline for presenting authors to register: 10 August, 2023


Submission Guidelines

When submitting a case report, authors should select one of the corresponding topics above and answer “Yes” to the following question during the submission process : “Please confirm whether your abstract is a case report?”

All abstract submitters should be prepared to present their abstract as an oral communication or poster presentation.

Abstract presenters that would like to be excluded from presenting an oral communication can indicate their preference in the appropriate box on the online abstract submission form.


1. Abstract Format




– The person submitting the abstract should be the presenting author of the work.

– The ESVS respects the Vancouver agreement on authorship, and in light of that, only accepts a maximum of 8 authors from single-centre reports. In case of a multicentre study, and in particular multi-national collaborations, more than 8 authors are accepted.

Abstract Title

– The title should provide a reasonable completed description of the study that was conducted, and sometimes even foreshadow the findings. The title should be informative, concise and intelligible.

Abstract Body

The following format must be followed:

Introduction The introduction should be a brief section designed to inform of the relevance of the research and include a short history of relevant background that leads to a statement of the problem that is being addressed.

Methods       The methods section should contain sufficient information to be able to understand the experimental design, the analytical techniques and the statistics used in the study.

Results          The results section describes but does not interpret. The presentation data may be either chronological to correspond with the methods or in the order of most to least important.

Conclusion   The conclusions section should provide only conclusion of the study directly supported by the results, along with implications for clinical practice, avoiding speculation.

NOTE:  the “Case Reports” will need to follow a different structure, namely: Introduction, Case Description, Discussion

Abstract Layout

– Abstracts must be submitted in English.

– The total length of the abstract should be max. 700 words.

Graphics, Tables & Images

·       You can add a max of 2 tables and 2 images to your abstract.

·       A table/image file should be saved as an .jpeg or .png prior to upload.

·       The figure/table will be placed at the bottom of the abstract and may be resized.

·       Min./max. size of the image/table (pixels): 90/750, min./max. file size of the image/table (kB): 30/750.


References are allowed and are not included in the overall count of words of the abstract. Please add your references in a dedicated section of abstract submission system.

2. Submission Policy

Submitted abstracts must describe unpublished work (as full papers) at the moment of the submission. Unpublished abstracts presented at other scientific meetings (different specialties) will be accepted.

Abstracts will be published exactly as submitted. We kindly ask you to proofread abstracts carefully to avoid errors before they are submitted. No changes will be accepted after submission deadline. Any abstract considered unsuitable for reproduction will not be published.

The abstract submission deadline is April 3rd, 2023. ESVS does not take responsibility for abstracts that are not fully completed and submitted by this deadline date. Please ensure that your submission has been completed and you have received the confirmation e-mail.

Incomplete abstracts having “draft” status will not be processed or submitted for review.

An author may not revise or resubmit an abstract in order to make changes or corrections after the deadline; adding or removing authors after the submission deadline is not permitted. The abstract may be withdrawn or, if accepted, the error may be indicated during the presentation.

IMPORTANT NOTICE: The authors should avoid revealing the name of the city, institution (hospitals, medical centers, clinics) submitting the abstract, since the abstracts are evaluated in a blinded fashion. The reviewing committee understands the difficulty this may present in the case of multinational studies, nevertheless, authors are strongly encouraged to not reveal the origin of the work.

3. Review and Acceptance

All submitted abstracts will go through a blinded review process by 5-7 members of the scientific review committee of the 37th Annual Meeting. The abstracts will be reviewed according to the relevance to ESVS, objectivity of statements, suitability of methods, conclusions confirmed by objective results, scientific value, originality of work and overall impression.

  • Following the review process the final selection will be made by the Programme Committee of the meeting to define the format and schedule of each selected abstract.

    The notification of acceptance or rejection of your abstract will be sent out on 22 May 2023.

    The authors of accepted abstracts will need to fill in a dedicated form to confirm their presentations and presenting authors by 16 June, 2023. Failure to do so, will lead to the withdrawal of your abstract.

    IMPORTANT NOTICE: Should the presenting author be unable to present the abstract, one of the co-authors can present in his/her place. An email from the presenting author indicating the change is requested and must be received by the ESVS no later than 16 June 2023. No changes will be accepted after this date.  

    4. Presentation types


    A Fast-Track Presentation is a short oral communication of 4 minutes, presented in front of a Jury, on Tuesday, 26th September 2023. Each presentation is followed by 2 minutes for questions from the Jury or audience. The authors of the top-scored presentations from Fast – Track sessions will have the opportunity to present an extended version of their abstract in one of the Plenary Scientific Sessions on Wednesday or Thursday. Therefore, we encourage all presenters of selected abstracts to prepare a short version (4 minutes) and extended version (7 minutes) of their presentation, in case they are selected. All Fast-Track Presenters should therefore be available all days of the congress.


    40 highest-scoring abstracts following the review process will be asked to present their research in front of the jury at one of the Prize Fast-Track sessions on Tuesday, September 26th, 2023. The Jury will score presentations according to the following criteria: (1) Methodology;  (2) Originality;  (3) Importance to Vascular Surgery; (4) Quality of presentation incl. handling of questions.

    Following the Prize Fast-Track sessions, the authors of 10 highest scoring presentations will have an opportunity to present an extended version of their presentation  in front of a jury at the Prize session.  Therefore, we encourage all Prize abstract presenters to prepare a short version (4 minutes) and an extended version (7 minutes) of their presentation, in case they are selected. The announcement of 10 highest scoring abstract presentations will be made on Tuesday evening.


    The 10 highest-rated abstracts from Prize Fast-Track sessions will have an opportunity to present an extended version of their presentation during the Prize Scientific Session.

    The Jury of the Prize session will score presentations according to the following criteria: (1) Methodology;  (2) Originality;  (3) Importance to Vascular Surgery; (4) Quality of presentation incl. handling of questions. The presenting authors of the three top-scored Prize abstracts will be announced during the closing ceremony.


    The e-poster presentation sessions will be organised on Wednesday 27th September and Thursday 28th September. Each presenter will be allocated 4 minutes for presentation and 2 minutes to answer questions from a designated Jury member. All Poster presenters are required to be present next to their poster 5 minutes before the start of the session.

    The Jury will score posters according to the following criteria: (1) Originality;  (2) Scientific Level & Amount of Work;  (3) Clinical Relevance;  (4) Overall Poster Presentation. The presenting authors of the three top-scored posters will be announced during the closing ceremony.

    5. Registration and expenses

    All presenting authors of selected abstracts must register for the ESVS 37th Annual Meeting before 10th August, 2023.

    The ESVS will not cover costs incurred in submitting an abstract or poster, or for travel and accommodation costs for presenting authors.

    Failure to register for the ESVS Annual Meeting by the set deadline will lead to the withdrawal of your abstract(s).

    6. Publication of abstracts

    Authors of the abstracts presented as e-posters will be offered an open publication of their abstract at the supplement of EJVES Vascular Forum at €25 to cover the production costs.

    Authors of the abstracts presented during the Fast Track sessions which did not make it to the main scientific programme will be offered an open publication of their abstract at the supplement of EJVES Vascular Forum at €25 to cover the production costs.

    Authors of Prize abstracts and the abstracts accepted to the main scientific programme of the ESVS 37th Annual Meeting will be offered a publication of their abstract at EJVES free of charge.

The ESVS conference serves in my mind at the premier vascular surgery meeting in Europe. The opportunity to present at such a forum is an honour in and of itself, and one I hope to enjoy again in the future. Winning the prize for the best abstract of the meeting, when competing with so many other high quality and original studies was a true accolade and it is an achievement that I am very proud of

James Budge

Prize Winner - Best oral presentation 2022

To share research and experience at the European Society for Vascular Surgery is the ideal opportunity to come in contact with the top caliber of international vascular surgeons from Europe and around the world. I feel both obliged and honored to submit my research, and to be rewarded for my presentation is extremely gratifying. The international context and level of science at the Annual Meeting motivate me to continue my involvement, particularly with an increasing focus of my research in a more global perspective

Jacob Budtz-Lilly

Prize Winner - Best oral presentation 2022

I was very proud to have my work accepted for an abstract presentation at the last ESVS annual meeting. This opportunity gave me the chance to share and discuss my results with prestigious faculty members and attendees from all around the word.

This year, winning the Prize of the best abstract was a particular honour and encourages me to work on further scientific projects. Thus, I would be happy to submit my research next year.

Marie Corniquet

Prize Winner - Best poster presentation 2022

The ESVS Annual Meeting is one of the most recognized and important Vascular Surgery congress in the world. Key-opinion leaders present the current state of the art as well as the latest breaking trials and techniques. A wide variety of workshops and hands-on booths unlock the practical experience with new techniques and devices.

Furthermore, multiple fast-track and ESVT sessions allow for vascular surgeons, to present their work with the scientific community in a healthy and sharing environment.  The opportunity to expose your work with your international colleagues is a great fulfilling experience. Open debate, opinion sharing and new suggestions make it worthwhile.

It was with enormous honour that I received the news that me and my colleagues were awarded the 1st prize at the ESVT Scientific Session with the paper titled “Anterior tibial artery pseudoaneurysm leading to diagnosis of Cowden Syndrome – a case report”. It represents the international peer recognition and appreciation of our work.

Finally, the wholesome experience at the ESVS 36th Annual Meeting with its plenary sessions, workshops and open sessions is unquestionably a must for vascular surgeons, especially young ones, who are keen with learning, updating, practicing and sharing.

Carlos Veterano

Prize Winner - Best EVST presentation 2022

I appreciate the opportunity to present at the ESVS annual meeting a second time. I decided to write this abstract because I wanted to have the chance to discuss how crucial it is to plan and build a strategy for vascular surgery. Being awarded the second prize this time is immensely gratifying and fulfilling, and it has undoubtedly encouraged me to submit again in the future. Participating in such significant events is, in my opinion, a fantastic opportunity for vascular faculty and trainees

Dorelly Martínez

Prize Winner - Best EVST presentation 2022

I submitted my abstract to this meeting for mainly two reasons: one, the opportunity to share my pre-clinical research results and two, to be informed and updated on the current knowledge in the area of vascular surgery.

Participating in this meeting was a fantastic experience, both personally and professionally. It was great to see how people received my research, even if it was not as surgically oriented as the rest of the meeting.  I think it’s important to keep a link between pre-clinical research, which is what I do, and clinical/surgical research and procedures.

It is an honour to be selected to present at the Prize Session. Wining is just the cherry on top! For me, it feels like a recognition for my research. And a sign that it is important and interesting to other people.

Amanda Balboa Ramilo

Prize Winner - Best oral presentation 2021

Approaching the end of my PhD, I was keen to share my findings with the European Society for Vascular Surgery.  Presenting to the vascular surgery community and receiving insightful feedback and questions from leaders in the field was a great opportunity for which I am grateful.  I was delighted to be awarded a prize in recognition of this research to which I have dedicated the last three years.  I look forward to continued engagement with the Society in future as a great platform for learning and professional development, as well as sharing the findings of the next phase of research.

Mohamed Abdelhalim

Prize Winner - Best oral presentation 2021

Feedback E-Library
Give us your feedback about our E-Library !
How would you rate your experience?
Do you have any additional comment?
Thank you for submitting your feedback!